Coronavirus India Latest Updates: Fresh Cases Fall But Single-Day Deaths Rise
Fresh Covid-19 cases in India declined but single-day deaths rose even as recoveries outnumbered new infections.
India added 12,509 fresh cases in the last 24 hours, with the tally rising above to 3.43 crore in the world's second-most populous country, according to the Health Ministry's update as of 8 a.m. on Nov. 6. Active cases remain below 1.5 lakh.
Key figures:
Total confirmed cases: 3,43,44,683
Total number of active cases: 1,46,950
Total patients cured/discharged/migrated: 3,37,37,468
Total deaths: 4,60,265
Number of fresh cases in last 24 hours: 10,929
One-day recoveries: 12,509
One-day deaths: 392
As of 8 a.m. on Nov. 6, 2021
Meanwhile, India has vaccinated more than 107.7 crore people, with 20,75,942 doses administered in the last 24 hours, the Health Ministry data showed.
The World Health Organization has also granted emergency use authorisation for Bharat Biotech Ltd.'s Covid-19 vaccine Covaxin.
Bulk of the doses administered in India were that of Serum Institute of India's Covishield, developed by Oxford University and AstraZeneca. Russia's Sputnik V has been administered in small numbers. While shots from Johnson & Johnson and Moderna Inc. have been granted approval, they aren't being used as of now. The country has also granted emergency-use approval to its first DNA-based three-dose vaccine developed by Cadila Healthcare Ltd.
Global Update:
Globally, the coronavirus cases have topped 24.85 crore, with more than 50 lakh deaths. Over 710 crore vaccine doses have been administered across the world.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.